Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Fochon Pharmaceuticals patents Bcl-2 inhibitors

Nov. 22, 2021

Biopolar Hongye (Nantong) Pharmaceutical synthesizes JAK2 inhibitors

Nov. 19, 2021

Beijing Tide Pharmaceutical identifies GTPase KRAS inhibitors

Nov. 19, 2021

Betta Pharmaceuticals patents new compounds for cancer

Nov. 19, 2021

Hangzhou Innogate Pharma divulges SYK and JAK2 kinase inhibitors

Nov. 19, 2021

Shanghai Licheng Biotechnology divulges CLRN3-targeting nucleic acids

Nov. 18, 2021

Betta Pharmaceuticals identifies PTPN11 inhibitors

Nov. 18, 2021

GNT Biotech & Medicals presents new HDAC inhibitors

Nov. 18, 2021

Medshine Discovery discloses new MAPK inhibitors

Nov. 18, 2021

Novel STING agonist RVU-27065 shows potency in EMT6 breast cancer model

Nov. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...